Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Interactive Effects of Doxazosin and 3,4-Methylenedioxymethamphetamine (MDMA) in Healthy Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01386177

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Completed

Start Date: July 2011

Last Update: December 11, 2018

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: The purpose of this study is to determinate the effect of a pre-treatment with doxazosin, a alpha1-adrenergic receptor blocker, on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). The investigators hypothesize that doxazosin will attenuate the cardiovascular and subjective response to MDMA.

Conditions:
  • Mood Disorder
  • Substance-Related Disorders
  • Amphetamine-Related Disorders


Total execution time in seconds: 0.3741979598999